Cited by

• Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing's syndrome.

  Pan H, Tian AL, Chen H, Xia Y, Sauvat A, Moriceau S, Lambertucci F, Motiño O, Zhao L, Liu P, Mao M, Li S, Zhang S, Joseph A, Durand S, Aprahamian F, Luo Z, Ou Y, Shen Z, Xue E, Pan Y, Carbonnier V, Stoll G, Forveille S, Leduc M, Cerrato G, Cerone A, Maiuri MC, Castinetti F, Brue T, Wang H, Ma Y, Martins I, Kepp O, Kroemer G. Pan H, et al. Nat Metab. 2024 Nov 22. doi: 10.1038/s42255-024-01170-0. Online ahead of print. Nat Metab. 2024. PMID: 39578649
• Endogenous Cushing's Syndrome Due to Right Adrenal Adenoma Presenting With Bilateral Leg Oedema and Skin Ulceration.

  Suzuki M, Watari T. Suzuki M, et al. Cureus. 2024 Oct 8;16(10):e71103. doi: 10.7759/cureus.71103. eCollection 2024 Oct. Cureus. 2024. PMID: 39525240 Free PMC article.
• The conundrum of differentiating Cushing's syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis.

  Hinojosa-Amaya JM, González-Colmenero FD, Alvarez-Villalobos NA, Salcido-Montenegro A, Quintanilla-Sánchez C, Moreno-Peña PJ, Manzanares-Gallegos DM, Gutiérrez-Dávila LF, Castillo-Morales PL, García-Campa M, González-González JG, Varlamov E, Rodriguez-Gutiérrez R, Fleseriu M. Hinojosa-Amaya JM, et al. Pituitary. 2024 Aug;27(4):345-359. doi: 10.1007/s11102-024-01408-w. Epub 2024 Jun 18. Pituitary. 2024. PMID: 38888685
• Current and Emerging Pharmacological Therapies for Cushing's Disease.

  Divaris E, Kostopoulos G, Efstathiadou ZA. Divaris E, et al. Curr Pharm Des. 2024;30(10):757-777. doi: 10.2174/0113816128290025240216110928. Curr Pharm Des. 2024. PMID: 38424426 Review.
• Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency.

  Kang H, Park SS, Kim YH, Lim HS, Lee MK, Lee KR, Kim JH, Kim YH. Kang H, et al. Endocrinol Metab (Seoul). 2024 Feb;39(1):164-175. doi: 10.3803/EnM.2023.1792. Epub 2024 Jan 3. Endocrinol Metab (Seoul). 2024. PMID: 38171208 Free PMC article.